Filing Details

Accession Number:
0001104659-18-014883
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-05 17:25:09
Reporting Period:
2018-03-01
Accepted Time:
2018-03-05 17:25:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1491576 Tesaro Inc. TSRO Pharmaceutical Preparations (2834) 272249687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1699305 Orlando Oliveira C/O Tesaro, Inc.
1000 Winter Street
Waltham MA 02451
Svp & Gm, International No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-01 4,375 $0.00 10,930 No 4 M Direct
Common Stock Acquisiton 2018-03-01 1,483 $0.00 12,413 No 4 M Direct
Common Stock Disposition 2018-03-02 337 $54.86 12,076 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2018-03-01 4,375 $0.00 4,375 $0.00
Common Stock Restricted Stock Units Disposition 2018-03-01 1,483 $0.00 1,483 $0.00
Common Stock Restricted Stock Units Acquisiton 2018-03-01 18,182 $0.00 18,182 $0.00
Common Stock Employee Stock Option (right to buy) Acquisiton 2018-03-01 31,954 $0.00 31,954 $55.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,750 No 4 M Direct
4,447 No 4 M Direct
18,182 No 4 A Direct
31,954 2028-03-01 No 4 A Direct
Footnotes
  1. This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
  2. The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $54.80 to $54.87, inclusive. The reporting person undertakes to provide to TESARO, any security holder of TESARO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. Each restricted stock unit represents a contingent right to receive one share of TESARO common stock.
  4. The RSUs were granted on March 1, 2016, and the remaining RSUs vest in two equal annual installments on each of March 1, 2019 and 2020.
  5. The RSUs were granted on March 1, 2017, and the remaining RSUs vest in three equal annual installments on each of March 1, 2019, 2020 and 2021.
  6. The RSUs vest in four equal annual installments beginning on March 1, 2019.
  7. The option vests in 48 equal monthly installments beginning on April 1, 2018.